Search

everythinglearnresearchcommunity

for

Search:↓

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Iron deficiency might contribute to hair loss in women.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Pigs without the Hairless gene showed skin and thymus changes, useful for studying human hair disorders.

Accurate diagnosis of pseudolymphomatous folliculitis is crucial to avoid mistaking it for more serious conditions.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.